TP53 and acute myeloid leukemia: The most common subtypes of AML are characterized by NPM1-mutations (30%), myelodysplasia-related mutations (AML-MR; defined by the presence of mutation in one of 8 or 9 genes; 20%), and TP53-mutation or complex karyotype (15%) 10.